The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Van Besien, Koen
One or more keywords matched the following items that are connected to Van Besien, Koen
Item TypeName
Concept Hodgkin Disease
Academic Article Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma.
Academic Article Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas.
Academic Article Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium.
Academic Article Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.
Academic Article NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Academic Article Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
Academic Article Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Academic Article Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure.
Academic Article Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).
Academic Article Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
Academic Article Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.
Academic Article Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.
Academic Article Personalized treatment of lymphoma: promise and reality.
Academic Article Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.
Academic Article Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Academic Article Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
Academic Article Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
Academic Article Great expectations? Conditioning with busulfan, melphalan and thiotepa in recurrent Hodgkin lymphoma.
Academic Article Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Academic Article Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.
Academic Article Allogeneic transplant for peripheral T-cell lymphoma: a sparkle of hope and many questions.
Academic Article Allotransplantation for patients age =40 years with non-Hodgkin lymphoma: encouraging progression-free survival.
Academic Article Superiority of reduced-intensity conditioning for Hodgkin's lymphoma.
Academic Article High-dose melphalan allows durable engraftment of allogeneic bone marrow.
Academic Article Therapeutic options for patients with Hodgkin's disease and non-Hodgkin's lymphoma who relapse after autologous transplant.
Academic Article Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
Academic Article Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma.
Academic Article Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
Academic Article Activity of single agent temsirolimus (CCI-779) in non-mantle cell non-Hodgkin lymphoma subtypes.
Academic Article Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin Lymphoma.
Search Criteria
  • Hodgkin Disease